Mark DiPaolo is a Partner and the General Counsel of Sarissa Capital Management LP, a registered investment advisor, since May 2013. Sarissa Capital focuses on improving the strategies of companies in the Healthcare sector to enhance shareholder value. From 2005 to 2013, Mr. DiPaolo served as a senior member of Icahn Capital’s investment team, working on all aspects of Carl Icahn’s activist investing strategy. During that time, Mr. DiPaolo worked closely with Mr. Icahn on many activist campaigns. Prior to working with Icahn Capital, Mr. DiPaolo was an attorney at Willkie Farr & Gallagher LLP. Mr. DiPaolo is a director of Innoviva Inc. and Novelion Therapeutics Inc., both publicly traded healthcare companies. Mr. DiPaolo received his B.A. degree from Fordham University and his J.D. degree from Georgetown University.